Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Pediatrics Office Under Murphy Plans To Recruit Review Div. Liaisons

Executive Summary

FDA's Office of Pediatric Drug Development & Special Initiatives hopes to attract an expert from every drug review division to serve as a liaison in assessing pediatric drug applications.

You may also be interested in...



CDER Deputy Galson Will Run Drug Center For At Least Six Months

Center for Drug Evaluation & Research Deputy Director Steve Galson, MD, will be acting center director during the period when FDA is expected to announce a decision on forced Rx-to-OTC switches

FDA Pediatric/Counterterrorism Office Will Announce Division Directors In Fall

FDA's Office of Counterterrorism and Pediatric Drug Development (OCTAP) is expected to announce directors for its separate counterterrorism and pediatric drug divisions in the fall

FDA Pediatric/Counterterrorism Office Will Announce Division Directors In Fall

FDA's Office of Counterterrorism and Pediatric Drug Development (OCTAP) is expected to announce directors for its separate counterterrorism and pediatric drug divisions in the fall

Related Content

UsernamePublicRestriction

Register

PS038533

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel